Regulation & Compliance

As employers pull back coverage for pricey weight-loss drugs, a new partnership offers a flexible way to provide access without breaking the budget.

As cyber threats in healthcare escalate, CIVIE's HITRUST e1 certification signals a new standard for patient data protection in AI-driven medical tech.

A new, AI-powered platform from Trust & Will offers free tools to solo attorneys, aiming to shift estate planning from a one-off task to a proactive relationship.

At NRF 2026, HPE unveiled new fault-tolerant servers and AI-native networking to ensure every transaction is secure and every insight is actionable.

With a new name and a laser focus on its lead hemophilia A drug, Metagenomi Therapeutics signals a major shift from platform tech to clinical powerhouse.

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

Petco is refinancing $1.5B in debt to extend maturities while reaffirming its financial outlook. Is this a sign of strength or underlying strain?

ConcertAI and Foundation Medicine unite to create a huge dataset of 500k patients, using AI to accelerate the hunt for new life-saving cancer drugs.

Cogent Biosciences is set for a transformative year, eyeing three FDA submissions and a launch for its lead drug, with a deep pipeline to follow.

Promising new 96-week data shows Vir's therapy could redefine care for severe hepatitis delta, as its oncology pipeline and financial runway also advance.

The genomics leader posted a 41% revenue surge in 2025 and projects profitability, yet its stock tumbled on what some see as conservative 2026 guidance.

Interim data suggests LX2020 is well-tolerated and may reduce dangerous arrhythmias by targeting the root cause of PKP2-associated cardiomyopathy.

Backed by Purolator, a massive network expansion by Williams Pharmalogistics aims to reshape Canada's temperature-controlled medical delivery landscape.

The pediatric device firm posted 15% growth to $236.1M in 2025, issuing strong 2026 guidance fueled by its specialty bracing and European expansion.

Annexon is poised for a landmark year with potential first-in-class drugs for GBS and GA, promising to reset treatment standards and offer new hope.

Princeton-based EDETEK will present its AI-powered clinical trial ecosystem at the J.P. Morgan conference, aiming to capture a slice of a booming market.

Palladyne AI launches its IQ 2.0 software, a low-code platform aiming to overhaul defense manufacturing in line with new government mandates.

After a lengthy battle, a New York financier is cleared of all charges. Now, his lawsuit against FINRA and Capital Group challenges the system itself.

Teladoc Health's enhanced service integrates specialist consults and data analytics, moving beyond urgent care to reshape healthcare costs and patient outcomes.

CoinEx's consistent token burning removes over 166M CET in a year, signaling a long-term commitment to scarcity and value in a competitive market.